| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 1.012.309.380 $ | 97,71 | 43.745.938 | |||||||
| Jazz Pharmaceuticals plc | Jazz Pharmaceuticals plc | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 57.469.480 $ | 5,55 | 283.073 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 49.158.498 $ | 4,75 | 141.974 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 48.279.829 $ | 4,66 | 368.999 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 43.144.094 $ | 4,16 | 61.019 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 41.642.198 $ | 4,02 | 97.436 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 38.274.575 $ | 3,69 | 48.962 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 29.760.220 $ | 2,87 | 129.742 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 29.217.428 $ | 2,82 | 214.314 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 29.174.212 $ | 2,82 | 202.430 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 25.961.052 $ | 2,51 | 81.426 | |
| Dianthus Therapeutics, Inc. | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 23.776.152 $ | 2,30 | 270.799 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 21.681.614 $ | 2,09 | 248.985 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 20.940.139 $ | 2,02 | 215.190 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 20.796.559 $ | 2,01 | 319.652 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 19.211.233 $ | 1,85 | 102.531 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 17.811.396 $ | 1,72 | 135.273 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 17.145.972 $ | 1,66 | 241.119 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 16.755.170 $ | 1,62 | 54.138 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 16.559.970 $ | 1,60 | 141.080 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 24.090.829 $ | 2,33 | 323.584 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 15.355.704 $ | 1,48 | 205.400 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 21.646.703 $ | 2,09 | 316.426 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 15.125.074 $ | 1,46 | 567.545 | |
| EyePoint, Inc. | EyePoint, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 14.830.134 $ | 1,43 | 1.123.495 | |
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 13.150.757 $ | 1,27 | 14.071 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 12.563.138 $ | 1,21 | 188.240 | |
| Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 12.229.203 $ | 1,18 | 332.496 | |
| Benitec Biopharma, Inc. | Benitec Biopharma, Inc. | EC | 08205P209 | Long | Börsenkurs (Stufe 1) | 15.737.667 $ | 1,52 | 1.306.033 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 11.741.216 $ | 1,13 | 505.651 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 10.559.482 $ | 1,02 | 492.743 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 10.388.144 $ | 1,00 | 649.259 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 10.303.200 $ | 0,99 | 161.063 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 9.868.219 $ | 0,95 | 33.421 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 9.677.869 $ | 0,93 | 447.635 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 9.112.522 $ | 0,88 | 519.232 | |
| Solid Biosciences, Inc. | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 9.103.880 $ | 0,88 | 1.253.978 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 8.360.135 $ | 0,81 | 387.402 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 8.338.380 $ | 0,80 | 145.674 | |
| Alkermes plc | Alkermes plc | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 7.852.306 $ | 0,76 | 232.937 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 7.593.230 $ | 0,73 | 73.400 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 7.574.650 $ | 0,73 | 75.535 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 6.935.903 $ | 0,67 | 123.767 | |
| Achieve Life Sciences, Inc. | Achieve Life Sciences, Inc. | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 9.893.583 $ | 0,95 | 2.282.331 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 6.858.070 $ | 0,66 | 82.737 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 6.510.969 $ | 0,63 | 659.005 | |
| Alto Neuroscience, Inc. | Alto Neuroscience, Inc. | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 10.399.357 $ | 1,00 | 405.275 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 5.468.076 $ | 0,53 | 379.464 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 5.454.534 $ | 0,53 | 487.012 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 5.397.600 $ | 0,52 | 765.617 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 5.361.455 $ | 0,52 | 187.726 | |
| VeraDermics, Inc. | VeraDermics, Inc. | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 5.336.496 $ | 0,52 | 53.904 | |
| Inventiva SACA | Inventiva SACA | EC | 46124U107 | Long | Börsenkurs (Stufe 1) | 4.973.986 $ | 0,48 | 969.588 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 8.667.871 $ | 0,84 | 676.121 | |
| Palisade Bio, Inc. | Palisade Bio, Inc. | EC | 696389402 | Long | Börsenkurs (Stufe 1) | 4.239.820 $ | 0,41 | 2.119.910 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 5.654.775 $ | 0,55 | 136.424 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 4.108.998 $ | 0,40 | 8.579 | |
| Obsidian Therapeutics, Inc. | Obsidian Therapeutics, Inc., Series C | EC | Long | Modellwert (Stufe 2) | 3.667.504 $ | 0,35 | 3.667.504 | ||
| Kailera Therapeutics, Inc. | Kailera Therapeutics, Inc. | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 3.659.625 $ | 0,35 | 146.385 | |
| enGene Therapeutics, Inc. | enGene Therapeutics, Inc. | EC | 29286X101 | Long | Börsenkurs (Stufe 1) | 3.537.429 $ | 0,34 | 486.579 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 3.493.664 $ | 0,34 | 175.121 | |
| Ray Therapeutics, Inc. | Ray Therapeutics, Inc., Series B | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.399.269 $ | 0,33 | 1.389.029 | |
| Sensei Biotherapeutics, Inc. | Sensei Biotherapeutics, Inc., Series B | EP | Long | Schätzwert (Stufe 3) | beschränkt | 4.661.847 $ | 0,45 | 48.903 | |
| Jade Biosciences, Inc. | Jade Biosciences, Inc. | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 3.360.588 $ | 0,32 | 137.729 | |
| Context Therapeutics, Inc. | Context Therapeutics, Inc. | EC | 21077P108 | Long | Börsenkurs (Stufe 1) | 3.301.246 $ | 0,32 | 1.398.833 | |
| Immix Biopharma, Inc. | Immix Biopharma, Inc. | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 3.188.314 $ | 0,31 | 357.034 | |
| Candid Therapeutics, Inc. | Candid Therapeutics, Inc. | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.046.668 $ | 0,29 | 2.735.200 | |
| Lycia LLC | Lycia LLC, Series C | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.017.588 $ | 0,29 | 859.370 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 3.016.868 $ | 0,29 | 232.783 | |
| Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 2.668.174 $ | 0,26 | 108.067 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 2.529.670 $ | 0,24 | 46.433 | |
| SpyGlass Pharma, Inc. | SpyGlass Pharma, Inc. | EC | 85220G109 | Long | Börsenkurs (Stufe 1) | 2.507.984 $ | 0,24 | 109.328 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 2.381.893 $ | 0,23 | 81.852 | |
| Candid, Inc. | Candid, Inc., Series B | EC | Long | Schätzwert (Stufe 3) | beschränkt | 2.372.462 $ | 0,23 | 1.519.609 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 2.356.482 $ | 0,23 | 60.891 | |
| Sartorius AG | Sartorius AG | EP | DE0007165631 | Long | Modellwert (Stufe 2) | 2.350.384 $ | 0,23 | 9.200 | |
| Verastem, Inc. | Verastem, Inc. | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 2.193.522 $ | 0,21 | 401.744 | |
| Acumen Pharmaceuticals, Inc. | Acumen Pharmaceuticals, Inc. | EC | 00509G209 | Long | Börsenkurs (Stufe 1) | 2.508.795 $ | 0,24 | 1.049.705 | |
| Artiva Biotherapeutics, Inc. | Artiva Biotherapeutics, Inc. | EC | 04317A107 | Long | Börsenkurs (Stufe 1) | 1.974.999 $ | 0,19 | 192.871 | |
| Satellos Bioscience, Inc. | Satellos Bioscience, Inc. | EC | 80401L803 | Long | Börsenkurs (Stufe 1) | 2.725.250 $ | 0,26 | 343.237 | |
| Sartorius Stedim Biotech | Sartorius Stedim Biotech | EC | FR0013154002 | Long | Modellwert (Stufe 2) | 1.866.598 $ | 0,18 | 10.100 | |
| Zentalis Pharmaceuticals, Inc. | Zentalis Pharmaceuticals, Inc. | EC | 98943L107 | Long | Börsenkurs (Stufe 1) | 1.764.556 $ | 0,17 | 440.039 | |
| Adicet Bio, Inc. | Adicet Bio, Inc. | EC | 007002207 | Long | Börsenkurs (Stufe 1) | 1.700.154 $ | 0,16 | 225.186 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 1.678.425 $ | 0,16 | 186.907 | |
| JATT II Acquisition Corp. | JATT II Acquisition Corp. | EC | KYG507651092 | Long | Börsenkurs (Stufe 1) | 1.542.374 $ | 0,15 | 146.753 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 1.528.447 $ | 0,15 | 90.709 | |
| Avalo Therapeutics, Inc. | Avalo Therapeutics, Inc. | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 1.495.132 $ | 0,14 | 111.577 | |
| Vicore Pharma Holding AB | Vicore Pharma Holding AB | EC | SE0007577895 | Long | Börsenkurs (Stufe 1) | 1.413.428 $ | 0,14 | 1.307.598 | |
| Eikon Therapeutics, Inc. | Eikon Therapeutics, Inc. | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 1.224.720 $ | 0,12 | 127.376 | |
| Cardiff Oncology, Inc. | Cardiff Oncology, Inc. | EC | 14147L108 | Long | Börsenkurs (Stufe 1) | 759.403 $ | 0,07 | 438.961 | |
| Carmot Therapeutics, Inc. | Carmot Therapeutics, Inc. | EC | Long | Schätzwert (Stufe 3) | 534.289 $ | 0,05 | 83.100 | ||
| IN8bio, Inc. | IN8bio, Inc. | EC | 45674E208 | Long | Börsenkurs (Stufe 1) | 488.162 $ | 0,05 | 332.083 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 461.850 $ | 0,04 | 186.984 | |
| Assembly Biosciences, Inc. | Assembly Biosciences, Inc., Series A | EC | Long | Schätzwert (Stufe 3) | 479.247 $ | 0,05 | 88.900 | ||
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 228.645 $ | 0,02 | 27.681 | |
| Sanofi SA | Sanofi SA, Escrow Account | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 2.333.755 | ||
| 1.012.309.380 $ | 97,71 | 43.745.938 |